The expiration date reflects the last day that the drug is guaranteed to perform at its peak
That means using nonirritating cleansers and moisturizers without alcohol or fragrance, and avoiding exfoliation products that can be harsh on the skin
RETATRUTIDE (GLP/GIP/GLUCAGON) Mecanismo de accin: Retatrutida es un agonista triple que activa GLP-1, GIP y el receptor de glucagn, diseado para imitar tres hormonas clave del metabolismo
View Shirley's Profile
When to seek medical attention: Persistent vomiting preventing adequate fluid intake Severe abdominal pain, particularly if localized to the upper right quadrant (potential gallbladder issues) Severe pain in the upper abdomen radiating to the back (possible pancreatitis) Signs of dehydration (dark urine, dizziness, decreased urination) Inability to tolerate any food or liquids for more than 24 hours Severe constipation with abdominal distension or vomiting (possible ileus/obstruction) Yellowing of skin/eyes with fever and abdominal pain Patients with significant vomiting or diarrhea should be monitored for signs of acute kidney injury, particularly those with pre-existing renal impairment or taking medications that affect kidney function
Bridging the Data Gap in GLP1 Therapy Management When we supported dozens of patients during their first three months on GLP1 therapy, a pattern became clear: confusion about detection fuels unnecessary worry, and clinicians spend time reconstructing timelines rather than deciding next steps
